Literature DB >> 7546902

Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression.

S Sonza1, A Maerz, S Uren, A Violo, S Hunter, W Boyle, S Crowe.   

Abstract

Monocytes from HIV-seronegative persons were analyzed for CD4 expression and susceptibility to infection with HIV-1 on the day of isolation and following 1, 2, and 7 days in culture. Although surface CD4 was readily detected on freshly isolated monocytes, these cells were relatively resistant to infection. After 1 to 2 days in culture, when surface expression of CD4 had decreased over 90% to near background levels, cells became susceptible to infection with HIV-1. CD4 expression on monocytes cultured for 7 days was more than four times higher than that on freshly isolated cells, and the cultured cells were fully permissive to infection. These observations suggest that the differing susceptibility of monocytes and monocyte-derived macrophages to infection with HIV-1 is not simply proportional to the level of surface CD4 expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546902     DOI: 10.1089/aid.1995.11.769

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

1.  Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Adrienne E Swanstrom; Gretja Schnell; Benhur Lee; James A Hoxie; Ronald Swanstrom
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

2.  Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages.

Authors:  S R Lewin; P Lambert; N J Deacon; J Mills; S M Crowe
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 3.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

4.  Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1.

Authors:  D L Tuttle; J K Harrison; C Anders; J W Sleasman; M M Goodenow
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  β-Catenin/TCF-4 signaling regulates susceptibility of macrophages and resistance of monocytes to HIV-1 productive infection.

Authors:  Yosra Aljawai; Maureen H Richards; Melanie S Seaton; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro.

Authors:  J Chang; H M Naif; S Li; J S Sullivan; C M Randle; A L Cunningham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.

Authors:  Jianbo Chen; Que Dang; Derya Unutmaz; Vinay K Pathak; Frank Maldarelli; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes.

Authors:  S Sonza; A Maerz; N Deacon; J Meanger; J Mills; S Crowe
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 9.  Host hindrance to HIV-1 replication in monocytes and macrophages.

Authors:  Anna Bergamaschi; Gianfranco Pancino
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

10.  Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages.

Authors:  Clare L V Westhorpe; Jingling Zhou; Nicole L Webster; Bill Kalionis; Sharon R Lewin; Anthony Jaworowski; William A Muller; Suzanne M Crowe
Journal:  J Leukoc Biol       Date:  2009-06       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.